Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
3. Med-tech trends: Medtronic, Johnson & Johnson, Covidien, St. Jude, Boston Scientific the most talked about device makers in May
During the last month Medtronic (NYSE:MDT) reclaimed its lead of the internet trends race as it released its 4th-quarter and full-year earnings report with troubling implications for the ever-struggling cardiac rhythm management market.
The trouble with developing an entirely new modality for treating deadly cancers of the head and trunk is that you’re frequently explaining what you do and how you do it, but Novocure’s tumor-treating electromagnetic fields may help patients with chemo-resistant tumors regain their lives.
GOP Representatives could pass a bill repealing the 2.3% medical device excise tax by the end of this week, but that doesn’t mean the war is won.